US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States

Rajiv Saran, Bruce Robinson, Kevin C. Abbott, Lawrence Y.C. Agodoa, Jennifer Bragg-Gresham, Rajesh Balkrishnan, Nicole Bhave, Xue Dietrich, Zhechen Ding, Paul W. Eggers, Abduzhappar Gaipov, Daniel Gillen, Debbie Gipson, Haoyu Gu, Paula Guro, Diana Haggerty, Yun Han, Kevin He, William Herman, Michael HeungRichard A. Hirth, Jui Ting Hsiung, David Hutton, Aya Inoue, Steven J. Jacobsen, Yan Jin, Kamyar Kalantar-Zadeh, Alissa Kapke, Carola Ellen Kleine, Csaba P. Kovesdy, William Krueter, Vivian Kurtz, Yiting Li, Sai Liu, Maria V. Marroquin, Keith McCullough, Miklos Z. Molnar, Zubin Modi, Maria Montez-Rath, Hamid Moradi, Hal Morgenstern, Purna Mukhopadhyay, Brahmajee Nallamothu, Danh V. Nguyen, Keith C. Norris, Ann M. O'Hare, Yoshitsugu Obi, Christina Park, Jeffrey Pearson, Ronald Pisoni

Research output: Contribution to journalEditorialpeer-review

748 Citations (Scopus)
Original languageEnglish
Pages (from-to)A7-A8
JournalAmerican Journal of Kidney Diseases
Volume73
Issue number3
DOIs
Publication statusPublished - Mar 1 2019

Funding

Funding for the USRDS Coordinating Center is provided under contract to University of Michigan Kidney Epidemiology and Cost Center ( HHSN 276201400001C ). Dr Balkrishnan receives consulting income from Merck and Company. Dr Bragg-Gresham is a consultant with the Medical Education Institute (MEI) involving quality-of-life performance measures. Dr Herman is chair of the Data Safety Monitoring Board for Merck Sharp & Dohme. Dr Kalantar-Zadeh has financial interests with the following entities: Abbott, AbbVie, Alexion, Amgen, AstraZeneca, Aveo, Chugai, DaVita, Fresenius, Genentech, Haymarket Media, Hospira, Kabi, Keryx, Novartis, Pfizer, Relypsa, Resverlogix, Sandoz, Sanofi, Shire, Vifor, UpToDate, and ZS Pharma. Dr Kovesdy is a consultant for AstraZeneca, Bayer, and Sanofi-Aventis. Dr Morgenstern is a consultant at Arbor Research Collaborative for Health. Dr O’Hare received grant funding from NIH, CDC, VA HSR&D; she also received speaker fees and honoraria from Dialysis Clinic Inc., Fresenius Medical Care, the University of Alabama at Birmingham, the University of Pennsylvania, and the Hammersmith Hospital in London. Dr Sim has investigator-initiated research grants from Keryx Pharmaceuticals, Mallinckrodt Pharmaceuticals, and Otsuka Pharmaceuticals. The remaining authors declare that they have no relevant financial interests. Funding for the USRDS Coordinating Center is provided under contract to University of Michigan Kidney Epidemiology and Cost Center (HHSN 276201400001C).

ASJC Scopus subject areas

  • Nephrology

Cite this